Skip to main content
. 2024 Sep 12;15(5):2145–2156. doi: 10.21037/jgo-24-516

Table 1. Participant characteristics.

Baseline characteristic Control group (n=214) Experimental group (n=100)
Age (years) 55.50 (50.00, 62.50) 55.00 (52.00, 71.00)
Sex ratio (M/F) 144/70 60/40
CEA (ng/mL) 1.91 (1.25, 2.22) 2.20 (1.22, 10.51)*
CA19-9 (ng/mL) 10.79 (7.33, 13.78) 9.53 (5.58, 23.78)*
CA242 (ng/mL) 4.53 (2.91, 7.43) 5.25 (2.53, 23.00)*
CA50 (ng/mL) 5.98 (4.45, 8.10) 5.69 (3.09, 14.97)*
WBC (×109/L) 6.82 (5.34, 7.95) 5.80 (4.70, 7.08)
NEUT WBC (×109/L) 3.61 (2.98, 5.06) 3.22 (2.57, 4.14)
LYM WBC (×109/L) 2.14 (1.82, 2.45) 1.86 (1.33, 2.28)*
MON WBC (×109/L) 0.42 (0.32, 0.52) 0.37 (0.32, 0.52)
PLT WBC (×109/L) 237.0 (221.0, 277.5) 247.0 (199.0, 311.0)
HGB (g/L) 143.0 (124.5, 157.0) 122.0 (104.0, 135.0)*
MPV (fL) 9.80 (8.93, 10.00) 10.00 (8.95, 11.00)
NLR 1.63 (1.24, 2.76) 1.78 (1.33, 2.31)*
PLR 114.08 (95.47, 123.26) 145.45 (116.67, 189.04)*
UREA (mmol/L) 4.80 (3.93, 5.53) 4.60 (3.60, 5.80)
CREA (μmol/L) 79.50 (65.50, 83.25) 66.00 (59.67, 81.00)
UA (mmol/L) 333.75 (280.68, 382.58) 310.60 (272.80, 385.80)*
TP (g/L) 68.70 (66.33, 73.05) 68.20 (62.80, 71.00)*
ALB (g/L) 40.45 (39.10, 43.18) 39.40 (38.00, 40.60)*
TBIL (μmol/L) 13.95 (8.83, 20.72) 9.09 (6.84, 15.80)*
ALT (U/L) 16.50 (12.75, 26.00) 14.00 (10.00, 23.00)
AST (U/L) 20.50 (16.00, 25.50) 17.00 (14.00, 20.00)
ALP (U/L) 69.50 (58.75, 84.25) 66.00 (56.00, 77.00)
PT (s) 11.65 (11.20, 12.30) 11.80 (11.40, 12.50)*
APTT (s) 26.85 (25.30, 28.80) 27.40 (25.90, 28.60)
TT (s) 17.70 (16.98, 18.10) 17.30 (16.80, 17.90)*
FIB (g/L) 2.60 (2.33, 3.09) 2.69 (2.40, 3.44)*
INR 0.97 (0.94, 1.03) 0.99 (0.96, 1.05)*

Data are presented as numbers or median (Q1, Q3). *, P<0.05, versus the control group. CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; CA242, carbohydrate antigen 242; CA50, carbohydrate antigen 50; WBC, white blood cell count; NEUT, absolute neutrophil value; LYM, absolute lymphocyte value; MON, absolute monocyte value; PLT, platelet count; HGB, hemoglobin; MPV, mean platelet volume; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; UREA, urea nitrogen; CREA, creatinine; UA, uric acid; TP, total protein; ALB, albumin; TBIL, total bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; FIB, fibrinogen; INR, international normalized ratio; Q1, 25th percentile; Q3, 75th percentile.